Most Anticipated Earnings: SEA-T, CRDL-T and more Canadian Companies Reporting Earnings this Week (Aug 18-22)

Opinion about PPTA-Q: He's not comfortable with the permitting process, but Trump administration might be able to help with permits. Gold-centric, but also antimony (which the US believes is a defense metal). 

Opinion about SEA-T: Owns shares in company.Be patient in terms of returns.Present gold prices will not generate returns for shareholders. Higher gold prices important for shareholders to see return on capital. Good proxy for higher gold prices. 

Opinion about DV-X: Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Latest results pretty good, with the highest silver assays reported to date. Strike length has increased and high-grade veins continue to be hit. IF (a big if) DV can connect the two zones then mineralization will increase materially. More infill drilling needs to be done,…

Opinion about TLO-T: Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research Recent news has been generally positive, with the commencement of a draft guideline supporting domestic nickel preference and strong enforcement mechanisms implementing IRA Foreign Entity of Concern requirements. It also struck a $115M deal for a nickel ore processing plant that will…

Opinion about NDM-T: Embroiled in environmental issues. But new life under the Trump administration, so all bets are off. Gold and copper in Alaska. Stock's almost tripled since the election. Current project is massive, ~$6B. Nice to be able to get permitting, but how are they going to finance it?

Opinion about OGN-X: Selling one royalty to Triple Flag Royalties for stock. Likes it right now because company's valued at less than total value of OGN and Triple Flag combined, there's a merger arbitrage in play. The transaction is accretive to both parties. Shareholders should take the share option, rather than the cash option, and…

Opinion about BEW-X: Caught attention of market as numbers continued to ramp up. Very big move, now consolidating. Will probably eventually get taken out for its technology and customer base. Trades thinly. May itself be looking for a small acquisition.

Opinion about DAN-X: This has an igneous phosphate deposit, as opposed to the sedimentary type of deposit that comes from Morocco. They have a positive feasibility study and a very high CapX, and are working through the permitting cycle. What they need is one of the big agricultural companies to do a buyout and develop…

Opinion about TK-X: They have quality zinc deposits in Peru, but the zinc price is the issue, so is it a good time to sell it now? They will drill another 10,000 meters so find more high-grade. He escapes a scoping study by end-June. Has a flat chart though, reflecting the low zinc price. Zinc…

Opinion about WLF-X: Have received a notice of intent to make a takeover offer from one Australian zinc producer. Offer is at $3.90 a share. With take advantage of the market liquidity and usually money to advantage.

Opinion about ARU-X: (A Top Pick Aug 20/08. Up 22.3%.) Acquired by Kinross (K-T).

Opinion about AU-X: Attractive exploration company. Compared to other companies, not as good. Does not own shares. Waiting for more drill results before investing in company. Attractive political jurisdiction. Good management team and shareholder base.

Opinion about GRSL-X: (A Top Pick Sep 01/20, Down 64%) Disappointing. Numbers haven't been coming as fast as the market would like. Over time, he has faith the resource will materialize from the drilling.

Opinion about JG-X: He likes their recent deal with Barrick. JG controls the real estate in Japan while Barrick spends money on exploration.

Opinion about CLZ-X: Has a silver discovery in the Durango area of Mexico. It is a joint venture with Orex (REX-X) earning in. They are carried for 35% once Orex has earned in. A very interesting project. They drilled into an alteration zone and hit good mineralization which is fairly consistent and looks like it…

Opinion about CRDL-T: COVID-19 heart issues? The company makes a synthetic CBD. Their original work saw CBD helped to reduce inflammation of the heart. It is expected they will start to re-purpose their product for COVID patients. This would help accelerate testing by about 2 years. This could lead to product being sold in Canada…

Opinion about ROMJ-X: Billy Kawasaki’s Insights. A cannabis cultivator out of BC that is a micro-cap. It trades on the TSX Venture Exchange. Current earnings per share is at -0.19. It started trading in September and has largely stayed flat since the IPO. The marijuana space continues to face pressure so it may be wise…

Opinion about BABY-X: Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. A plant-based baby nutrition company. Deal with Walmart has been positive development, giving them higher exposure. Trading at 15x sales, which is expensive considering the current revenu base of $1.8M. Has had a good quarter. Balance sheet looks good and sales should…

Opinion about ASG-X: It was all " gung ho" about 2 years ago. It is difficult to find out what is going on. Management have been rather shy for a long time. Overall revenues have not risen dramatically for a long time. There are a lot of competitors. He needs to look more closely into…

Opinion about MDX-X: Brazilian order? He owns warrants and his wife works as a consultant for them. They have orders for 500 units for a melanoma testing product. The delivery is subject to approval by authorities in Brazil. This could lead to hardware sales by June and revenues that begin to show up in Q4.…

Opinion about NSCI-X: They take a large nuclear magnetic resonance machine and shrink it down to a desk top size. They now have a high def version. Theirs is better than their nearest competitor. It won't be profitable until 2021.

Opinion about PHA-X: They are like an Uber for healthcare staff: allows hospitals to quickly hiring nurses for hospitals, and PHA transports patients and staff. Not well known. The problem, is that haven't been able to expand outside Quebec--and he's looking for this. That said, you can own this now.

Opinion about IAN-CSE: Comparable to Medmen Enterprises. American-based sales of legal cannabis, with operations in six states, including the 48 million people of Massachusetts, Florida and New York. They have one of the 10 licenses in New York and one of the 13 in Florida. This is one of her largest holdings. Â There have…

Opinion about BU-T: Extracts protein from vegetables like canola, peas, and soy. Has 285 patents. There is negligible revenue despite the company being around for more than 20 years. Difficult to apply fundamental analysis. Too speculative for him. Need to see revenue and profit.

Opinion about SECU-X: They do physical and cybersecurity. A very small-cap, early-stage company. If they execute in the next 2-3 years, they will be great.

Opinion about VEXT-CSE: There's been a lot of focus on cannabis in the US. Last November, Arizona legalized recreational weed and are starting to sell that. VEXT operates in many states, but particularly AZN. VEXT is still under the radar, but he expects them to grow rapidly, because they had a head start as a…

Opinion about EVGN-X: Best way to play renewable gas globally. Pure play. A way to be cleaner in using natural gas. Companies like FTS are making it part of their mandate, and it's a major customer of EVGN. Two transformational acquisitions. Tremendous growth. Need a tough stomach for the volatility. Approved to buy back shares.…

Opinion about BR-T: Brewery. Tough for them to compete. Have a strong following in Alberta but his concern would be if their product has a strong enough niche to compete with the big companies.

Opinion about CSW.A-T: Ace Beverage acquisition got him interested. Some really nice growth coming, but not all segments are growing. So it's not going to give him the consistent 10-15% growth rate of a great company. Last quarter showed 9%.

Opinion about CSW.B-T: He doesn’t know the seasonality on this, but the technicals show that it has been in an upward trend for quite a period of time. During the last little while, it has been in a trading range between around $19 and $22. It is not unusual for a lot of stocks in…

Opinion about HBFG-CSE: Incredible job scaling the business. Close to 500 franchises in development, which should take about 3-5 years. About $2-2.5M in revenue per quarter, anticipates a ramp up to ~$4M next year. Lots of faith in CEO -- a passionate and excellent entrepreneur, who's really good at identifying concepts early, buying them cheaply,…

Opinion about ENW-X: He owned the stock years ago. They dry things like food. They are now getting into the marijuana space. It has done very well lately but if they are going to get meaningful contracts, they are going to do well.

Opinion about MTLO-X: Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenue grew 57% YOY despite soft results in Q4 2021 relative to expectations. A strong second half of 2022 financial year is expected. Holds $8.5M in cash. In talks with Microsoft for a deal. Continues to trade at relatively low valuation. Results…

Opinion about NET.UN-X: Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Recent results were quite positive. It collected 100% of rent with an increase in revenue by 61%. Free cashflow is at $2.9M this quarter. They have added the Food Basics banner and acquired more land for development. Profit margins increased and cash…